Document:

Exhibit
10.4

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR UNLESS, IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE COMPANY, SUCH QUALIFICATION AND REGISTRATION ARE NOT REQUIRED.

 

COMMON
STOCK PURCHASE WARRANT

Waterside
Capital Corporation

 

	Warrant
    Shares: 1,000,000	Issue
    Date: March 16, 2022

 

Holder
name: Daniel Giancola

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, the holder named above or its permitted
assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Issue Date as set forth above (the “Issue Date”) and on or prior to 5:00 p.m. (Eastern
time) on the fifth anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase
from Waterside Capital Corporation, a company organized in the State of Nevada (the “Company”), up to the number of shares
set forth above (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b), subject to adjustment as set forth
herein.

 

Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Purchase Agreement”), dated as of the Issue Date, among the Company and the Holder. This
Warrant is subject to the terms and conditions of the Purchase Agreement and, in the event of a conflict between the Purchase Agreement
and this Warrant, the terms and conditions of this Warrant shall control. For purposes herein:

 

(a)
“Trading Market” means the OTC Markets or a United States or Canadian national securities exchange which is the primary trading
market for the Common Stock.

 

(b)
“Trading Day” means any day on which the Common Stock is traded or available for trading on the Trading Market.

 

(c)
“Transfer Agent” means the Company’s transfer agent for the Common Stock as in place at the applicable time.

 

    	 

    	 

    

 

Section
2. Exercise.

 

(a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Issue Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail with return receipt requested (or e-mail attachment to an e-mail with return receipt requested) of the
Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days
(as defined below) and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(c)(i)) following
the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise Price for the shares specified in the
applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has exercised the rights to purchase all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation together with the final Notice of Exercise
as delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases, and the records of the Company shall be deemed controlling in the absence of manifest
error. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this Section 2(a), following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.

 

(b)
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $1.75, subject to adjustment hereunder
(the “Exercise Price”).

 

(c)
Mechanics of Exercise.

 

	 	(i)	Delivery
    of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
    Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust
    Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system
    and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
    Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
    pursuant to Rule 144, and otherwise in book-entry format by recording the Holder as the beneficial owner of the Warrant Shares in
    the books and records of the Transfer Agent. The Warrant Shares shall not be certificated. The Warrant Shares shall be issued by
    the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
    Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
    Settlement Period, if applicable, after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share
    Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become
    the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
    of the Warrant Shares, provided that payment of the aggregate Exercise Price is received within the earlier of (i) two (2) Business
    Days and (ii) the number of Business Days comprising the Standard Settlement Period following delivery of the Notice of Exercise.
    As used herein, “Standard Settlement Period” means, if applicable, the standard settlement period, expressed in a number
    of Business Days, on the OTC Markets or a United States national securities exchange which is the primary trading market for the
    Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

    	2

     

    

 

	 	(ii)	Delivery
    of New Warrants Upon Partial Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
    a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
    Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant
    shall in all other respects be identical with this Warrant.
	 	 	 
	 	(iii)	Rescission
    Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(c)(i)
    by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.
	 	 	 
	 	(iv)	No
    Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
    this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
    shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
    by the Exercise Price or round up to the next whole share.
	 	 	 
	 	(v)	Charges,
    Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
    incidental expense of the Company in respect of the issuance of such Warrant Shares, all of which taxes and Company expenses shall
    be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
    by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
    this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
    and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
    thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to
    the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
    delivery of the Warrant Shares.

 

    	3

     

    

 

	 	(vi)	Closing
    of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
    Warrant, pursuant to the terms hereof.

 

(d)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and the Holder shall not have
the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution
Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing
sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include
the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but
shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of
this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the
unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any debt, preferred stock,
rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles
the holder thereof to receive, Common Stock) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,
for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder
that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(d) applies, the determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice
of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each
case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such
determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(d), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A)
the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement
by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common
Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or
its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
“Beneficial Ownership Limitation” shall be 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant, provided, further, however, that the
Beneficial Ownership Limitation may be increased by the Holder, at the election of the Holder, on not less than 61 days’ prior
notice to the Company, and the Beneficial Ownership Limitation shall continue to apply until such 61st day (or such later
date, as determined by the Holder, as may be specified in such notice of waiver). The provisions of this Section 2(d) shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(d) to correct this Section 2(d) (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this Section 2(d)
shall apply to a successor holder of this Warrant.

 

Section
3. Certain Adjustments.

 

(a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. By way of example
and not limitation, in the event of a forward split of the Common Stock following the Issue Date in which each share of Common Stock
is converted into two shares of Common Stock, the Exercise Price shall be reduced by 50%, and in the event of a reverse split of the
Common Stock following the Issue Date in which each two shares of Common Stock are converted into one share of Common Stock, the Exercise
Price shall be increased by 100%, in each case without adjustment to the number of Warrant Shares for which is Warrant remains exercisable.
Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.

 

    	4

     

    

 

(b)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of
its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any
reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock
held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to,
such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate
Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for
which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(d)
on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”)
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(b)
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity equivalent to the shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to
such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but
taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares
of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form
and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

(c)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a
given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

    	5

     

    

 

(d)
Notice to Holder. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and setting forth a brief
statement of the facts requiring such adjustment.

 

(e)
Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant, subject to the prior written consent of the Holder, reduce the then-current Exercise Price to any amount and
for any period of time deemed appropriate by the board of directors of the Company.

 

Section
4. Transfer of Warrant.

 

(a)
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d), this
Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the
Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed
by the Holder or its agent or attorney, together with proper evidence of succession, assignment, or authority to transfer as reasonably
acceptable to the Company, and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company as of the date of the assignment of this
Warrant.

 

(b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto and any changes to the Exercise
Price occurring prior to such issuance.

 

(c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for
all other purposes, absent actual notice to the contrary.

 

    	6

     

    

 

(d)
Transfer Restrictions.

 

	 	(i)	The Holder, as of the Issue Date as set forth above, represents
to the Company that such Holder is acquiring this Warrant for its own account for investment purposes and not with a view to the distribution
thereof or of the Warrant Shares. Notwithstanding any provisions contained in this Warrant to the contrary, this Warrant and the related
Warrant Shares shall not be transferable except pursuant to the proviso contained in the following sentence or upon the conditions specified
in this Section 4(d), which conditions are intended, among other things, to insure compliance with the provisions of the Securities Act
of 1933, as amended (the “Securities Act”) and applicable state law in respect of the transfer of this Warrant or such Warrant
Shares. The Holder by acceptance of this Warrant agrees that the Holder will not transfer this Warrant or the related Warrant Shares
prior to delivery to the Company of an opinion of the Holder’s counsel (as such opinion and such counsel are described in Section
4(d)(ii)) or until registration of such Warrant Shares under the Securities Act has become effective.

 

	 	(ii)	The Holder, by its acceptance hereof, agrees that prior to
any transfer of this Warrant or of the related Warrant Shares (other than pursuant to a registration under the Securities Act), the Holder
will give written notice to the Company of its intention to effect such transfer, together with an opinion of such counsel for the Holder
as shall be reasonably acceptable to the Company, to the effect that the proposed transfer of this Warrant and/or such Warrant Shares
may be effected without registration under the Securities Act. Upon delivery of such notice and opinion to the Company, the Holder shall
be entitled to transfer this Warrant and/or such Warrant Shares in accordance with the intended method of disposition specified in the
notice to the Company.

 

	 	(iii)	Each stock certificate representing Warrant Shares issued upon
exercise or exchange of this Warrant shall bear the following legend unless the opinion of counsel referred to in this Section 4(d) states
such legend is not required:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER
LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR
OTHER LOAN SECURED BY SUCH SECURITIES.”

 

    	7

     

    

 

Section
5. Miscellaneous.

 

(a)
No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as expressly
set forth in Section 3. In no event shall the Company be required to net cash settle an exercise of this Warrant.

 

(b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.

 

(c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.

 

(d)
Incorporation by Reference. The provisions of Article VI of the Purchase Agreement (Miscellaneous) are hereby incorporated herein
by reference, and shall apply to this Warrant as though fully set forth herein, provided that any reference there to the “Agreement”
shall be deemed a reference to this Warrant.

 

(e)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.

 

(f)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

(g)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company or
to the Company by the Holder shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

(h)
Governing Law. This Warrant, and all matters based upon, arising out of or relating in any way to this Warrant, including all
disputes, claims or causes of action arising out of or relating to this Warrant as well as the interpretation, construction, performance
and enforcement of this Warrant, shall be governed by the laws of the United States and the State of Nevada, without regard to any jurisdiction’s
conflict-of-laws principles.

 

    	8

     

    

 

(i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company. IN NO EVENT WILL ANY PARTY BE LIABLE TO ANY OTHER PARTY UNDER OR IN CONNECTION WITH THIS WARRANT OR IN
CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREIN FOR SPECIAL, GENERAL, INDIRECT, CONSEQUENTIAL, OR PUNITIVE OR EXEMPLARY DAMAGES,
INCLUDING DAMAGES FOR LOST PROFITS OR LOST OPPORTUNITY, EVEN IF THE PARTY SOUGHT TO BE HELD LIABLE HAS BEEN ADVISED OF THE POSSIBILITY
OF SUCH DAMAGE.

 

(j)
Remedies. The Company and the Holder, in addition to being entitled to exercise all rights granted by law, including recovery
of damages, will each be entitled to specific performance of its rights under this Warrant. The Company and the Holder each agrees that
monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant
and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.

 

(l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived only with the written consent of the Company
and the Holder.

 

(m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

(n)
Currency. All dollar amounts are in U.S. dollars.

 

(o)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

********************

 

(Signature
Page Follows)

 

    	9

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the Issue Date.

 

	 	Waterside
    Capital Corporation
	 	 	 
	 	By:	 /s/
    Ryan Schadel 
	 	Name:	Ryan
    Schadel
	 	Title:	Chief
    Executive Officer

 

	Agreed
    and accepted:	 
	 	 	 
	Daniel
Giancola

	 
	 	 	 
	By:	  /s/
    Daniel Giancola 	 
	Name:
    	Daniel
Giancola

	 

 

    	10

     

    

 

NOTICE
OF EXERCISE

 

TO: Waterside Capital Corporation

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if
any.

 

(2)
Payment shall be made in lawful money of the United States as set forth in the Warrant.

 

(3)
Please issue said Warrant Shares in the name of the undersigned.

 

(4)
The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

The
Warrant Shares shall be delivered to the following DWAC Account Number (if applicable):

 

	 	 	 
	 	 	 
	 	 	 

 

	Name
    of Holder: 	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	Date:	 	________________________________

 

    	11

     

    

 

ASSIGNMENT
FORM

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to:

 

	Name:	 	 
	 	 	(Please
    Print)
	 	 	 
	Address:	 	 
	 	 	(Please
    Print)
	 	 	 
	Phone
    Number:	 	 
	 	 	 
	Email
    Address:	 	 
	 	 	 
	Dated:___________________
    ___,________________	 	 
	 	 	 
	Holder’s

    Signature:____________________________________
	 	 
	 	 	 

 

	Holder’s
    Address:

    
	 	 
	 	 	 
		 	 
		 	 
		 	 
		 	 
		 	 

 

    	12Exhibit
10.5

 

 

 

Securities
Purchase Agreement

 

By
and Among

 

Waterside
Capital Corporation

 

And

 

Tom
Zarro

 

Dated
as of March 16, 2022

 

 

 

    	 

    	 

    

 

TABLE
OF CONTENTS

 

	Article
    I. 	DEFINITIONS	1
	Section
    1.01 	Definitions.	1
	Section
    1.02 	Interpretive
    Provisions.	2
	 	 	 
	Article
    II. 	PURCHASE
    AND SALE; AGREEMENTS	3
	Section
    2.01 	Purchase
    and Sale.	3
	Section
    2.02 	Deliverables
    at Closing.	3
	Section
    2.03 	Closing.	3
	 	 	 
	Article
    III. 	REPRESENTATIONS
    AND WARRANTIES OF THE COMPANY	4
	Section
    3.01 	Authorization
    of Transactions.	4
	Section
    3.02 	Governmental
    Approvals; Non-contravention.	4
	Section
    3.03 	Brokers.	4
	 	 	 
	Article
    IV. 	REPRESENTATIONS
    AND WARRANTIES OF BUYER	4
	Section
    4.01 	Authorization
    of Transactions.	4
	Section
    4.02 	Governmental
    Approvals; Non-contravention.	5
	Section
    4.03	Investment
    Representations.	5
	Section
    4.04	Brokers.	6
	 	 	 
	Article
    V. 	INDEMNIFICATION	7
	Section
    5.01 	General
    Indemnification.	7
	Section
    5.02 	Procedures
    for Indemnification.	7
	Section
    5.03 	Payment.	7
	Section
    5.04 	Effect
    of Knowledge on Indemnification.	7
	 	 	 
	Article
    VI. 	MISCELLANEOUS	7
	Section
    6.01 	Notices.	7
	Section
    6.02 	Attorneys’
    Fees	8
	Section
    6.03 	Amendments;
    No Waivers; No Third-Party Beneficiaries.	8
	Section
    6.04 	Expenses.	9
	Section
    6.05 	Further
    Assurances.	9
	Section
    6.06	Successors
and Assigns; Benefit.	9
	Section
    6.07 	Governing
    Law; Etc.	9
	Section
    6.08 	Survival.	10
	Section
    6.09 	Resolution
    of Disputes.	10
	Section
    6.10 	Severability.	11
	Section
    6.11	Entire
Agreement.	11
	Section
    6.12 	Specific
    Performance.	11
	Section
    6.13 	Construction.	11
	Section
    6.14 	Counterparts.	11

 

	Exhibit
    A 	Certificate
    of Designation of Preferences and Rights of Series A Convertible Preferred Stock
	Exhibit
    B	Form
    of Warrant

 

    	i

    	 

    

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is entered into as of March 16, 2021 (the “Closing Date”), by
and among Waterside Capital Corporation, a Nevada corporation (the “Company”) and Tom Zarro (“Buyer”).
The Company and the Buyer may be collectively referred to herein as the “Parties” and individually as a “Party”.

 

WHEREAS,
the Company desires to issue and sell to the Buyer certain shares of Series A Convertible Preferred Stock, par value $0.0001 per share
(the “Series A Stock”) of the Corporation, which are convertible into shares of common stock, par value $0.0001 per share
of the Company (the “Common Stock”) and which have the rights and preferences as set forth in the Certificate of Designation
of Preferences and Rights of Series A Convertible Preferred Stock of the Corporation as attached hereto as Exhibit A (the “Certificate
of Designations”) and certain warrants to acquire shares of Common Stock, in each case on the terms set forth herein and the Buyer
wishes to purchase such securities on the terms and conditions provided for herein and the Parties desire to undertake the other actions
and enter into the other agreements as set forth herein;

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

Article
I. DEFINITIONS

 

Section
1.01 Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms, as used herein, have
the following meanings:

 

	 	(a)	“Affiliate”
    means, with respect to a specified Person, any other Person that directly or indirectly Controls, is Controlled by or is under common
    Control with, the specified Person.
	 	 	 
	 	(b)	“Business
    Day” means any day except Saturday, Sunday and any legal holiday or a day on which banking institutions in Nevada generally
    are authorized or required by Law or other governmental actions to close.
	 	 	 
	 	(c)	“Contract”
    means any contract, commitment, understanding or agreement (whether oral or written).
	 	 	 
	 	(d)	“Control”
    means (a) the possession, directly or indirectly, of the power to vote 10% or more of the securities or other equity interests of
    a Person having ordinary voting power, (b) the possession, directly or indirectly, of the power to direct or cause the direction
    of the management and policies of a Person, by contractor otherwise, or (c) being a director, officer, executor, trustee or fiduciary
    (or their equivalents) of a Person or a Person that controls such Person.
	 	 	 
	 	(e)	“Governmental
    Entity” means any federal, state, municipal, local or foreign government and any court, tribunal, arbitral body, administrative
    agency, department, subdivision, entity, commission or other governmental, government appointed, quasi-governmental or regulatory
    authority, reporting entity or agency, domestic, foreign or supranational.

 

    	1

    	 

    

 

	 	(f)	“Law”
    means any applicable foreign, federal, state or local law (including common law), statute, treaty, rule, directive, regulation, ordinances
    and similar provisions having the force or effect of law or an Order of any Governmental Entity.
	 	 	 
	 	(g)	“Liabilities”
    means liabilities, obligations or responsibilities of any nature whatsoever, whether direct or indirect, matured or un-matured, fixed
    or unfixed, known or unknown, asserted or un asserted, choate or inchoate, liquidated or unliquidated, secured or unsecured, absolute,
    contingent or otherwise, including any direct or indirect indebtedness, guaranty, endorsement, claim, loss, damage, deficiency, cost
    or expense.
	 	 	 
	 	(h)	“Losses”
    means any losses, damages, deficiencies, Liabilities, assessments, fines, penalties, judgments, actions, claims, costs, disbursements,
    fees, expenses or settlements of any kind or nature, including legal, accounting and other professional fees and expenses.
	 	 	 
	 	(i)	“Order”
    means any judgment, writ, decree, determination, award, compliance agreement, settlement agreement, injunction, ruling, charge, judicial
    or administrative order, determination or other restriction of any Governmental Entity or arbitrator.
	 	 	 
	 	(j)	“Person”
    means a natural person, a corporation, a limited liability company, a partnership, an association, a trust or any other entity or
    organization, including a government or political subdivision or any agency or instrumentality thereof.
	 	 	 
	 	(k)	“Securities
    Act” means the United States Securities Act of 1933, as amended, and the rules and regulation promulgated thereunder.
	 	 	 
	 	(l)	“Transactions”
    means the purchase and sale of the Securities and the other transactions contemplated under the Transaction Documents.
	 	 	 
	 	(m)	“Transaction
    Documents” means this Agreement, the Warrants and any other agreement, document, certificate or writing delivered or to be
    delivered in connection with this Agreement and any other document related to the Transactions related to the forgoing, including,
    without limitations, those delivered at the Closing.

 

Section
1.02 Interpretive Provisions. Unless the express context otherwise requires, the words “hereof,”
“herein,” and “hereunder” and words of similar import, when used in this Agreement, shall refer to this
Agreement as a whole and not to any particular provision of this Agreement; terms defined in the singular shall have a comparable
meaning when used in the plural, and vice versa; the terms “Dollars” and “$” mean United States Dollars,
unless otherwise specified herein; references herein to a specific Section, Subsection, Recital or Exhibit shall refer,
respectively, to Sections, Subsections, Recitals or Exhibits of this Agreement; wherever the word “include,”
“includes,” or “including” is used in this Agreement, it shall be deemed to be followed by the words
“without limitation”; references herein to any gender shall include each other gender; references herein to any Person
shall include such Person’s heirs, executors, personal representatives, administrators, successors and assigns; provided,
however, that nothing contained in this Section 1.02 is intended to authorize any assignment or transfer not otherwise permitted by
this Agreement; references herein to a Person in a particular capacity or capacities shall exclude such Person in any other
capacity; references herein to any contract or agreement (including this Agreement) mean such contract or agreement as amended,
supplemented or modified from time to time in accordance with the terms thereof; with respect to the determination of any period of
time, the word “from” means “from and including” and the words “to” and “until” each
means “to but excluding”; references herein to any Law or any license mean such Law or license as amended, modified,
codified, reenacted, supplemented or superseded in whole or in part, and in effect from time to time; and references herein to any
Law shall be deemed also to refer to all rules and regulations promulgated thereunder.

 

    	2

    	 

    

 

Article
II. PURCHASE AND SALE; AGREEMENTS

 

Section
2.01 Purchase and Sale.

 

	 	(a)	Subject
    to the terms and conditions of this Agreement, at the Closing (as defined below), the Company shall issue and sell to Buyer:

 

	 	(i)	The
    number of shares of Series A Stock as set forth on the signature page hereto (the “Share(s)” at a price of $50,000 per
    Share; and
	 	 	 
	 	(ii)	three
    warrants to acquire a number of shares of Common Stock, with each warrant being for 100,000 shares of Common Stock for each share
    of Series A Stock purchased, and with one warrant being at an exercise price of $1.30 per share, one warrant being at an exercise
    price of $1.50 per share, and one warrant being at an exercise price of $1.75, in each case subject to adjustment as set forth therein
    (each, a “Warrant” and collectively, the “Warrants).

 

	 	(b)	The
    Share(s) and the Warrants may be referred to herein collectively as the “Securities”.
	 	 	 
	 	(c)	The
    purchase price for the Securities shall be equal to the number of Share(s) being acquired multiplied by $50,000, set forth on the
    signature page hereof (the “Purchase Price”).

 

Section
2.02 Deliverables at Closing.

 

	 	(a)	At
    the Closing, Buyer shall deliver to the Company:

 

	 	(i)	The
    Purchase Price via a check payable to the Company or wire transfer pursuant to the wire transfer instructions as provided by the
    Company to Buyer; and
	 	 	 
	 	(ii)	a
    copy of each Warrant, each duly executed by the Buyer, or an authorized officer of the Buyer if Buyer is an entity.

 

	 	(b)	At
    the Closing, the Company shall deliver to the Buyer a copy of each Warrant, each duly executed by an authorized officer of the Company
    and shall record the Buyer as the applicable holder of the Share(s) in the books and records of the Company. The Share(s) shall not
    be certificated unless requested by the Buyer.

 

Section
2.03 Closing. On the terms set forth herein, the closing of the Transactions (the “Closing”) shall take place by
conference call and electronic communication (i.e., emails/pdf) or facsimile, with exchange of original signatures to follow by
mail, on the Closing Date and effective as of 11:59 p.m. Eastern time, on such date.

 

    	3

    	 

    

 

Article
III. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The
Company represents and warrants to Buyer that the following representations and warranties contained in this Article III are true and
correct as of the Closing Date:

 

Section
3.01 Authorization of Transactions. The Company is a corporation duly authorized and in good standing in the State of Nevada
and has the requisite power and capacity to execute and deliver the Transaction Documents to which it is a party and to perform its obligations
hereunder and thereunder. The execution, delivery and performance by the Company of the applicable Transaction Documents and the consummation
of the Transactions have been duly and validly authorized by all requisite action on the part of the Company. The Transaction Documents
to which the Company is a party have been duly and validly executed and delivered by The Company. Each Transaction Document to which
the Company is a party constitutes the valid and legally binding obligation of the Company, enforceable against the Company in accordance
with its terms and conditions, except to the extent enforcement thereof may be limited by applicable bankruptcy, insolvency or other
Laws affecting the enforcement of creditors’ rights or by the principles governing the availability of equitable remedies.

 

Section
3.02 Governmental Approvals; Non-contravention.

 

	 	(a)	No
    consent, Order, action or non-action of, or filing, notification, declaration or registration with, any Governmental Entity or Person
    is necessary for the execution, delivery or performance by the Company of this Agreement or any other Transaction Document to which
    the Company is a party.
	 	 	 
	 	(b)	The
    execution, delivery and performance by the Company of the Transaction Documents to which the Company is a party, and the consummation
    by the Company of the Transactions, do not (i) violate or conflict with any Law or Order to which the Company may be subject, or
    (ii) constitute a violation or breach of, be in conflict with, constitute or create (with or without due notice or lapse of time
    or both) a default (or give rise to any right of termination, modification, cancellation or acceleration) of any obligation under
    any Contract to which the Company is a party or to which the Company is subject or by which the Company’s properties, assets
    or rights are bound.

 

Section
3.03 Brokers. The Company has not engaged, or caused to be incurred any Liability or obligation to, any investment banker,
finder, broker or sales agent or any other Person in connection with the origin, negotiation, execution, delivery or performance of
the Transaction Documents to which it is a party, or the Transactions.

 

Article
IV. REPRESENTATIONS AND WARRANTIES OF BUYER

 

Buyer
represents and warrants to the Company that the following statements contained in this Article IV are true and correct as of the Closing
Date:

 

Section
4.01 Authorization of Transactions. Buyer is a natural person or is an entity duly formed and qualified under the laws
of the jurisdiction of its formation or organization, and has the requisite power and capacity to execute and deliver the
Transaction Documents to which it is a party and to perform Buyer’s obligations hereunder and thereunder. The execution,
delivery and performance by Buyer of the applicable Transaction Documents and the consummation of the Transactions have been duly
and validly authorized by all requisite action on the part of Buyer. The Transaction Documents to which Buyer is a party have been
duly and validly executed and delivered by Buyer. Each Transaction Document to which Buyer is a party constitutes the valid and
legally binding obligation of Buyer, enforceable against Buyer in accordance with its terms and conditions, except to the extent
enforcement thereof may be limited by applicable bankruptcy, insolvency or other Laws affecting the enforcement of creditors’
rights or by the principles governing the availability of equitable remedies.

 

    	4

    	 

    

 

Section
4.02 Governmental Approvals; Non-contravention.

 

	 	(a)	No
    consent, Order, action or non-action of, or filing, notification, declaration or registration with, any Governmental Entity is necessary
    for the execution, delivery or performance by Buyer of this Agreement or any other Transaction Document to which Buyer is a party.
	 	 	 
	 	(b)	The
    execution, delivery and performance by Buyer of the Transaction Documents to which Buyer is a party, and the consummation by Buyer
    of the Transactions, do not violate any Laws or Orders to which Buyer is subject or violate, or, if Buyer is an entity, breach or
    conflict with any provision of Buyer’s organizational documents.

 

Section
4.03 Investment Representations.

 

	 	(a)	For
    purposes of this Section 4.03, the term “Securities” shall include, to the extent applicable, the shares of Series A
    Stock and the Warrants being acquired, and the shares of Common Stock that may be obtained by the Buyer on any conversion of the
    Series A Stock or exercise of the Warrants.
	 	 	 
	 	(b)	Buyer
    understands and agrees that the consummation of this Agreement including the delivery of the Securities as contemplated hereby constitute
    the offer and sale of securities under the Securities Act and applicable state statutes and that the Securities are being acquired
    for Buyer’s own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales
    registered or exempted from registration under the Securities Act.
	 	 	 
	 	(c)	Buyer
    is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D under the Securities Act.
	 	 	 
	 	(d)	Buyer
    understands that the Securities are being offered and sold to Buyer in reliance upon specific exemptions from the registration requirements
    of United States federal and state securities Laws and that the Company is relying upon the truth and accuracy of, and Buyer’s
    compliance with, the representations, warranties, agreements, acknowledgments and understandings of Buyer set forth herein in order
    to determine the availability of such exemptions and the eligibility of Buyer to acquire the Securities.
	 	 	 
	 	(e)	At
    no time was Buyer presented with or solicited by any leaflet, newspaper or magazine article, radio or television advertisement, or
    any other form of general advertising or solicited or invited to attend a promotional meeting otherwise than in connection and concurrently
    with such communicated offer. Buyer is not purchasing the Securities acquired by Buyer hereunder as a result of any “general
    solicitation” or “general advertising,” as such terms are defined in Regulation D under the Securities Act, which
    includes, but is not limited to, any advertisement, article, notice or other communication regarding the Securities acquired by Buyer
    hereunder published in any newspaper, magazine or similar media or on the internet or broadcast over television, radio or the internet
    or presented at any seminar or any other general solicitation or general advertisement.

 

    	5

    	 

    

 

	 	(f)	Buyer
    is acquiring the Securities for Buyer’s own account as principal, not as a nominee or agent, for investment purposes only,
    and not with a view to, or for, resale, distribution or fractionalization thereof in whole or in part and no other person has a direct
    or indirect beneficial interest in the Securities. Further, Buyer does not have any contract, undertaking, agreement or arrangement
    with any person to sell, transfer or grant participations to such person or to any third person, with respect to the Securities.
	 	 	 
	 	(g)	Buyer,
    either alone or together with Buyer’s representatives, has such knowledge, sophistication and experience in business and financial
    matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated
    the merits and risks of such investment.
	 	 	 
	 	(h)	Buyer
    understands that no United States federal or state agency or any other governmental or state agency has passed on or made recommendations
    or endorsement of the Securities or the suitability of the investment in the Securities nor have such authorities passed upon or
    endorsed the merits of the transactions set forth herein.
	 	 	 
	 	(i)	Any
    legend required by the securities laws of any state to the extent such laws are applicable to the Securities and the shares of Common
    Stock received by Buyer on conversion or exercise thereof shall be included on any certificates representing the Securities and the
    shares of Common Stock received by Buyer on conversion or exercise thereof Shares, which legend shall be in the following form or
    a substantially similar legend:

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED
UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED
UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY
TO THE COMPANY, SUCH QUALIFICATION AND REGISTRATION ARE NOT REQUIRED. ANY TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE
IS FURTHER SUBJECT TO OTHER RESTRICTIONS, TERMS AND CONDITIONS WHICH ARE NOT SET FORTH HEREIN.

 

Section
4.04 Brokers. Buyer has not engaged any investment banker, finder, broker or sales agent or any other Person in
connection with the origin, negotiation, execution, delivery or performance of any Transaction Document to which it is a party, or
the Transactions.

 

    	6

    	 

    

 

Article
V. INDEMNIFICATION

 

Section
5.01 General Indemnification. Each Party (the “Indemnifying Party”) agrees to indemnify, defend and hold harmless
the other Party and such other Party’s Affiliates and each of their respective directors, officers, managers, partners,
employees, agents, equity holders, successors and assigns (each, an “Indemnified Party”), from and against any and all
Losses incurred or suffered by any Indemnified Party arising out of, based upon or resulting from any breach of any representation
or warranty of the Indemnifying Party herein or breach by the Indemnifying Party of, or any failure the Indemnifying Party to
perform, any of the covenants, agreements or obligations contained in or made pursuant to this Agreement or the Transaction
Documents by the Indemnifying Party.

 

Section
5.02 Procedures for Indemnification. In the event that an Indemnified Party shall incur or suffer any Losses in respect of
which indemnification may be sought under this Article V against the Indemnifying Party, the Indemnified Party shall assert a claim
for indemnification by providing a written notice (the “Notice of Loss”) to the Indemnifying Party stating the nature
and basis of such indemnification. The Notice of Loss shall be provided to the Indemnifying Party as soon as practicable after the
Indemnified Party becomes aware that it has incurred or suffered a Loss.

 

Section
5.03 Payment. Upon a determination of liability under this Article V the Indemnifying Party shall pay or cause to be paid to
the Indemnified Party the amount so determined within five (5) Business Days after the date of such determination. If there should
be a dispute as to the amount or manner of determination of any indemnity obligation owed under this Agreement, the Indemnifying
Party shall nevertheless pay when due such portion, if any, of the obligation that is not subject to dispute. Upon the payment in
full of any amounts due under this Article V with respect to any claim, the Indemnifying Party shall be subrogated to the rights of
the Indemnified Party against any Person with respect to the subject matter of such claim.

 

Section
5.04 Effect of Knowledge on Indemnification. The right to indemnification, reimbursement or other remedy based upon any
representations, warranties, covenants and obligations set forth in this Agreement shall not be affected by any investigation
conducted with respect to, or any knowledge acquired (or capable of being acquired) at any time, whether before or after the
execution and delivery of this Agreement, with respect to the accuracy or inaccuracy of or compliance with any such representation,
warranty, covenant or obligation. The waiver of any condition based upon the accuracy of any representation or warranty, or on the
performance of or compliance with any covenant or obligation, shall not affect the right to indemnification, reimbursement or other
remedy based upon such representations, warranties, covenants or obligations.

 

Article
VI. MISCELLANEOUS

 

Section
6.01 Notices.

 

	 	(a)	Any
    notice or other communications required or permitted hereunder shall be in writing and shall be sufficiently given if personally
    delivered to it or sent by email, overnight courier or registered mail or certified mail, postage prepaid, addressed as follows:

 

if
to the Company, to:

 

Waterside
Capital Corporation

Attn:
Ryan Schadel

PO
Box 1571

Cumming,
Georgia, 30028

Email:
rschadel21@gmail.com

 

    	7

    	 

    

 

With
a copy, which shall not constitute notice, to:

 

Anthony
L.G., PLLC

Attn:
John Cacomanolis

625
N. Flagler Drive, Suite 600

West
Palm Beach, FL 33401

Email:
jcacomanolis@anthonypllc.com

 

If
to the Buyer, to the address for notices as set forth on the signature page hereof.

 

	 	(b)	Any
    Party may change its address for notices hereunder upon notice to each other Party in the manner for giving notices hereunder.
	 	 	 
	 	(c)	Any
    notice hereunder shall be deemed to have been given (i) upon receipt, if personally delivered, (ii) on the day after dispatch, if
    sent by overnight courier, (iii) upon dispatch, if transmitted by email with return receipt requested and received and (iv) three
    (3) days after mailing, if sent by registered or certified mail.

 

Section
6.02 Attorneys’ Fees. In the event that any Party institutes any action or suit to enforce this Agreement or to secure
relief from any default hereunder or breach hereof, the prevailing Party shall be reimbursed by the losing Party for all costs,
including reasonable attorneys’ fees, incurred in connection therewith and in enforcing or collecting any judgment rendered
therein.

 

Section
6.03 Amendments; No Waivers; No Third-Party Beneficiaries.

 

	 	(a)	This
    Agreement may be amended, modified, superseded, terminated or cancelled, and any of the terms, covenants, representations, warranties
    or conditions hereof may be waived, only by a written instrument executed by both of the Parties.
	 	 	 
	 	(b)	Every
    right and remedy provided herein shall be cumulative with every other right and remedy, whether conferred herein, at law, or in equity,
    and may be enforced concurrently herewith, and no waiver by any Party of the performance of any obligation by another Party shall
    be construed as a waiver of the same or any other default then, theretofore, or thereafter occurring or existing.
	 	 	 
	 	(c)	Neither
    any failure or delay in exercising any right or remedy hereunder or in requiring satisfaction of any condition herein nor any course
    of dealing shall constitute a waiver of or prevent any Party from enforcing any right or remedy or from requiring satisfaction of
    any condition. No notice to or demand on a Party waives or otherwise affects any obligation of that Party or impairs any right of
    the Party giving such notice or making such demand, including any right to take any action without notice or demand not otherwise
    required by this Agreement. No exercise of any right or remedy with respect to a breach of this Agreement shall preclude exercise
    of any other right or remedy, as appropriate to make the aggrieved Party whole with respect to such breach, or subsequent exercise
    of any right or remedy with respect to any other breach.
	 	 	 
	 	(d)	Notwithstanding
    anything else contained herein, no Party shall seek, nor shall any Party be liable for, consequential, punitive or exemplary damages,
    under any tort, contract, equity, or other legal theory, with respect to any breach (or alleged breach) of this Agreement or any
    provision hereof or any matter otherwise relating hereto or arising in connection herewith.

 

    	8

    	 

    

 

Section
6.04 Expenses. Unless otherwise contemplated or stipulated by a Transaction Document, all costs and expenses incurred in
connection with this Agreement shall be paid by the Party incurring such cost or expense.

 

Section
6.05 Further Assurances. At and following the Closing, each Party shall execute and deliver such documents and other papers
and take such further action as may be reasonably required to carry out the provisions of the Transaction Documents.

 

Section
6.06 Successors and Assigns; Benefit. This Agreement shall be binding upon and shall inure to the benefit of the Parties and
their respective successors and permitted assigns. No Party shall have any power or any right to assign or transfer, in whole or in
part, this Agreement, or any of its rights or any of its obligations hereunder, including, without limitation, any right to pursue
any claim for damages pursuant to this Agreement or the transactions contemplated herein, or to pursue any claim for any breach or
default of this Agreement, or any right arising from the purported assignor’s due performance of its obligations hereunder,
without the prior written consent of each of the other Parties and any such purported assignment in contravention of the provisions
herein shall be null and void and of no force or effect. Other than as specifically set forth herein, including in Article V,
nothing in this Agreement shall confer on any Person other than the Parties, and their respective successors and permitted assigns,
any rights, remedies, obligations, or Liabilities under or by reason of this Agreement.

 

Section
6.07 Governing Law; Etc.

 

	 	(a)	This
    Agreement, and all matters based upon, arising out of or relating in any way to the Transactions or the Transaction Documents, including
    all disputes, claims or causes of action arising out of or relating to the Transactions or the Transaction Documents as well as the
    interpretation, construction, performance and enforcement of the Transaction Documents, shall be governed by the laws of the United
    States and the State of Nevada, without regard to any jurisdiction’s conflict-of-laws principles.
	 	 	 
	 	(b)	SUBJECT
    TO Section 6.09, ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS
    OR THE CONTEMPLATED TRANSACTIONS SHALL BE INSTITUTED SOLELY IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF
    THE STATE OF GEORGIA, IN EACH CASE LOCATED IN FORSYTH COUNTY, GEORGIA AND EACH PARTY IRREVOCABLY SUBMITS TO THE PERSONAL JURISDICTION
    OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING. THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY OBJECTION TO THE LAYING
    OF VENUE OF ANY SUIT, ACTION OR ANY PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT TO PLEAD OR CLAIM IN ANY SUCH COURT
    THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

    	9

    	 

    

 

	 	(c)	EACH
    PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL
    PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS, THE PERFORMANCE THEREOF OR THE
    FINANCINGS CONTEMPLATED THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE,
    AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION,
    SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS
    AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 6.07(c).
	 	 	 
	 	(d)	Each
    of the Parties acknowledge that each has been represented in connection with the signing of this waiver by independent legal counsel
    selected by the respective Party and that such Party has discussed the legal consequences and import of this waiver with legal counsel.
    Each of the Parties further acknowledge that each has read and understands the meaning of this waiver and grants this waiver knowingly,
    voluntarily, without duress and only after consideration of the consequences of this waiver with legal counsel.

 

Section
6.08 Survival. The representations and warranties in this Agreement shall survive the Closing for a period of 12 months from
the Closing Date, and no claim for indemnification may be made after such time. All covenants and agreements in this Agreement, and such
provisions herein as required to give effect to the same, will survive until fully performed; provided, however, that, nothing herein
shall prevent a Party from making any claim hereunder, or relieve any other Party from any liability hereunder, after such time for any
breach thereof.

 

Section
6.09 Resolution of Disputes. Except as otherwise provided herein, all controversies, disputes or actions between the Parties
arising out of the Transactions or this Agreement, including their respective Affiliates, owners, officers, directors, agents and
employees, arising from or relating to this Agreement shall on demand of either party be submitted for arbitration to in accordance
with the rules and regulations of the American Arbitration Association. The arbitration shall be conducted by one arbitrator jointly
selected by each Party who is a party to the Dispute, provided, however, that if such Parties are unable to agree on the identity of
the arbitrator within 10 Business Days of commencement of efforts to do so, each Party who is a party to the Dispute shall select
one arbitrator and the arbitrators so selected shall select a final arbitrator, and the final arbitrator shall conduct the
arbitration alone. The Parties agree that, in connection with any such arbitration proceeding, each shall submit or file any claim
which would constitute a compulsory counterclaim (as defined by Rule 13 of the Federal Rules of Civil Procedures) within the same
proceeding as the claim to which it relates. Any such claim which is not submitted or filed in such proceeding shall be barred. The
arbitrator shall be instructed to use every reasonable effort to perform its services within seven days of request, and, in any
case, as soon as practicable. The Parties agree to be bound by the provisions of any limitation on the period of time by which
claims must be brought under Nevada law or any applicable federal law. The arbitrator(s) shall have the right to award the relief
which he or she deems proper, consistent with the terms of this Agreement, including compensatory damages (with interest on unpaid
amounts from due date), injunctive relief, specific performance, legal damages and costs. The award and decision of the
arbitrator(s) shall be conclusive and binding on all Parties, and judgment upon the award may be entered in any court of competent
jurisdiction. Any right to contest the validity or enforceability of this award shall be governed exclusively by the United States
Arbitration Act. The arbitration shall be conducted in Cumming, Georgia. The provisions of this Section 6.09 shall continue in full
force and effect subsequent to and notwithstanding the expiration or termination of this Agreement.

 

    	10

    	 

    

 

Section
6.10 Severability. If any provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law,
or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long
as the economic or legal substance of the Transactions is not affected in any manner adverse to any Party. Upon such determination
that any provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the Parties as closely as possible in an acceptable manner to the end that the
Transactions are fulfilled to the extent possible.

 

Section
6.11 Entire Agreement. The Transaction Documents constitute the entire agreement between the Parties with respect to the
subject matter hereof and thereof and supersede all prior agreements and understandings, both oral and written, between the Parties
with respect to the subject matter hereof and thereof.

 

Section
6.12 Specific Performance. Each Party agrees that irreparable damage would occur if any provision of this Agreement were not
performed in accordance with the terms hereof and that each Party shall be entitled to seek specific performance of the terms hereof
in addition to any other remedy at law or in equity.

 

Section
6.13 Construction. The table of contents and headings contained in this Agreement are for reference purposes only and will
not affect in any way the meaning or interpretation of this Agreement. In the event of a conflict between language or amounts
contained in the body of this Agreement and language or amounts contained in the Exhibits attached hereto, the language or amounts
in the body of the Agreement shall control. References to Articles or Sections shall refer to those portions of this Agreement. The
use of the terms “hereunder,” “hereof,” “hereto” and words of similar import shall refer to this
Agreement as a whole and not to any particular Article, Section or clause of or Exhibit to this Agreement.

 

Section
6.14 Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each of the Parties and delivered to the other
Parties, it being understood that each Party need not sign the same counterpart. A facsimile copy or electronic transmission of a
signature page shall be deemed to be an original signature page.

 

[Signature
page follows]

 

    	11

    	 

    

 

IN
WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the Closing Date.

 

	 	Waterside Capital Corporation
	 	 	 
	 	By:	/s/
    Ryan Schadel 
	 	Name:	Ryan
    Schadel
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	Tom Zarro

	 	 	 
	 	By:	/s/
    Tom Zarro 
	 	Name:	Tom Zarro

 

	 	Address
    for notices:
	 	 
	 	Tom Zarro

	 	 
	 	 
	 	Email:
	 

 

	Number of shares of Series A Stock to be acquired:	 	10 Shares
	Resulting total Purchase Price (at $50,000 per share):	 	$ 500,000

 

    	12

    	 

    

 

Exhibit
A

Certificate
of Designation of Preferences and Rights of Series A Convertible Preferred Stock

 

(Attached)

 

    	 

    	 

    

 

Exhibit
B

Form
of Warrant

 

(Attached)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]